Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vicplas InternationalSGX:569 PB Ratio is 0.57 as of Aug. 03, 2026, which is 37% below its 10-year median of 0.90. The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Vicplas International ranks better than 90.86% on this metric.
Vicplas International Ltd stock PB Ratio (=0.57) is close to 1-year low of 0.52.
The historical rank and industry rank for Vicplas International's PB Ratio or its related term are showing as below:
SGX:569'
s PB Ratio Range Over the Past 10 Years
Min: 0.49 Med: 0.9 Max: 4.92
Current: 0.57
During the past 13 years, Vicplas International's highest PB Ratio was 4.92. The lowest was 0.49. And the median was 0.90.
SGX:569's PB Ratio is ranked better than 90.86% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs SGX:569: 0.57
During the past 12 months, Vicplas International's average Book Value Per Share Growth Rate was -8.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -2.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 3.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Vicplas International was 9.90% per year. The lowest was -2.90% per year. And the median was 4.15% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Vicplas International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicplas International PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's PB Ratio distribution charts can be found below:
* The bar in red indicates where Vicplas International's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Vicplas International (SGX:569) has a PB Ratio of 0.57 as of Aug. 03, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Vicplas International and its competitors. This is 37% below median its historical median of 0.90. Over the past decade, Vicplas International's PB Ratio has ranged from 0.49 to 4.92. According to the industry distribution chart, Vicplas International ranks #72 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 9.1%.
Is Vicplas International's PB Ratio too high?
Vicplas International's current PB Ratio of 0.57 is 37% below median its 10-year median of 0.90. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 4.92. The Medical Devices & Instruments industry median PB Ratio is 2.07. Vicplas International's value of 0.57 is 72.5% below this industry median. Based on the distribution chart, Vicplas International ranks #72 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Vicplas International's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vicplas International ranks #72 out of 788 companies for PB Ratio. This places Vicplas International in the top 9% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.07. Vicplas International's value of 0.57 is 72.5% below this benchmark. Historically, Vicplas International's own PB Ratio has ranged from 0.49 to 4.92 over the past decade. While the company's 10-year median is 0.90 vs. the industry median of 2.07, Vicplas International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.07, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vicplas International's current PB Ratio of 0.57 is 72.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Vicplas International and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vicplas International's current PB Ratio is 0.57, which is 37% below median its own 10-year median of 0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicplas International stock overvalued right now?
Based on GuruFocus' analysis, Vicplas International (SGX:569) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.11, compared to a current price of S$0.08 — trading 30% below its estimated fair value. The current PB Ratio is 0.57, which is 37% below median its 10-year median of 0.90 and 72.5% below the Medical Devices & Instruments industry median of 2.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Vicplas International (SGX:569), the current PB Ratio is 0.57 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, Mexico, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:569 has been successfully added to your 
